Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
1 - 10 out of 46Page size: 10
  1. 2020
  2. Published

    Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

    Fotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D. A., Holst, Jens Juul, Vilsbøll, Tina, Knop, Filip Krag & Forbes, J. M., 2020, In: Nutrients. 12, 10, 12 p., 2928.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes

    Harris, S., Abrahamson, M. J., Ceriello, A., Charpentier, G., Evans, M., Lehmann, R., Liebl, A., Linjawi, S., Holt, R. I. G., Hosszúfalusi, N., Rutten, G. & Vilsbøll, Tina, 2020, In: Drugs. 80, 2, p. 147-165 19 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Counterregulatory responses to hypoglycaemia in totally pancreatectomised patients

    Baekdal, M., Lund, A., Baldassare, M. P. A., Rose, K., Egholk, J., Christensen, M. B., Hansen, C. P., Storkholm, J. H., Faber, Jens, Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2020, In: Diabetologia. 63, SUPPL 1, p. S95-S95

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study

    Larsen, E. L., Poulsen, Henrik Enghusen, Michaelsen, C., Kjær, L. K., Lyngbæk, M., Andersen, Emilie Skytte, Petersen-Bønding, C., Lemoine, C., Gillum, M., Jørgensen, Niklas Rye, Ploug, Thorkil, Vilsbøll, Tina, Knop, Filip Krag & Karstoft, K., 2020, In: Journal of Sports Sciences. 38, 18, p. 2080-2091

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial

    Johansen, N. J., Dejgaard, T. F., Lund, A., Schluentz, C., Larsen, E. L., Poulsen, Henrik Enghusen, Goetze, Jens P. , Møller, H. J., Vilsbøll, Tina, Andersen, H. U. & Knop, Filip Krag, 2020, In: Diabetes, Obesity and Metabolism. 22, 9, p. 1639-1647

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People

    Shadid, S., Abosi-Appeadu, K., De Maertelaere, A., Defreyne, J., Veldeman, L., Holst, Jens Juul, Lapauw, B., Vilsbøll, Tina & T'Sjoen, G., 2020, In: Diabetes Care. 43, 2, p. 411-417

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials

    Mann, J. F. E., Hansen, T., Idorn, T., Leiter, L. A., Marso, S. P., Rossing, Peter, Seufert, J., Tadayon, S. & Vilsbøll, Tina, 2020, In: The Lancet Diabetes and Endocrinology. 8, 11, p. 880-893 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

    Christensen, A. S., Haedersdal, S., Stoy, J., Storgaard, H., Kampmann, U., Forman, Julie Lyng, Seghieri, M., Holst, Jens Juul, Hansen, Torben, Knop, Filip Krag & Vilsbøll, Tina, 2020, In: Diabetes Care. 43, 9, p. 2025-2033 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

    Johansen, N. J., Dejgaard, T. F., Lund, A., Schluntz, C., Frandsen, C. S., Forman, Julie Lyng, Albrechtsen, Nicolai Jacob Wewer, Holst, Jens Juul, Pedersen-Bjergaard, Ulrik, Madsbad, Sten, Vilsbøll, Tina, Andersen, H. U. & Knop, Filip Krag, 2020, In: The Lancet Diabetes & Endocrinology. 8, 4, p. 313-324 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study

    Lund, A., Baekdal, M., Nielsen, S. W., Hansen, C. P., Storkholm, J. H., Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2020, In: Diabetologia. 63, Suppl. 1, p. S276 1 p., 574.

    Research output: Contribution to journal › Conference abstract in journal › Research

Previous 1 2 3 4 5 Next

ID: 33056950